1
1
1
1
1
1
7
7
5
5
2019
6
Company (15)University (1)
1 - 10 of 15
Sort by
Patent
Publication NumberUS 20190284193Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-04-05Publication Date2019-09-19
The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
Patent
Publication NumberWO 2019178368 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-03-14Publication Date2019-09-19
The disclosure is directed to compounds of Formula I, which are inhibitors of protein methyltransferase 5 (PRMT5). Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
Patent
Publication NumberWO 2019084470 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-10-26Publication Date2019-05-02
The disclosure is directed to compounds of Formula (I) and Formula (II). Formula (I) and Formula (II) and pharmaceutically acceptable salts or solvates thereof. Pharmaceutical compositions comprising compounds of Formula (I) or Formula (II), as well as methods of their use and preparation, are also described.
Patent
Publication NumberUS 20190048014Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-08-09Publication Date2019-02-14
The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
Patent
Publication NumberWO 2019032859 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-08-09Publication Date2019-02-14
The disclosure is directed to compounds of Formula (I). Pharmaceutical compositions comprising compounds of Formula (I), as well as methods of their use and preparation, are also described.
Patent
Publication NumberWO 2018152548 A4Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-02-20Publication Date2018-10-11
The disclosure is directed to compounds of Formula I, Formula II, Formula III, Formula IV, Formula V, or Formula VI: Methods of their use in inhibiting a protein arginine methyltransferase 5 (PRMT5) enzyme and treating disease, as well as methods of their preparation are also described.
Patent
Publication NumberWO 2018160855 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-03-01Publication Date2018-09-07
The disclosure is directed to compounds of Formula I, Formula II, Formula III, and Formula IV: (I) (II) (III) (IV) Methods of their use and preparation are also described.
Patent
Publication NumberWO 2018160824 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-03-01Publication Date2018-09-07
The disclosure is directed to compounds of Formula I, Formula II, Formula III, or Formula IV: Methods of their use and preparation are also described.
Patent
Publication NumberWO 2018152501 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-02-20Publication Date2018-08-23
The disclosure is directed to compounds of Formula I, Formula II, Formula III, or Formula IV, Formula V, Formula VI, Formula VII, or Formula VIII : Methods of their use in inhibiting a protein arginine methyltransferase 5 (PRMT5) enzyme and treating disease, as well as methods of their preparation are also described.
Patent
Publication NumberWO 2018085818 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2017-11-07Publication Date2018-05-11
The disclosure is directed to compounds of Formula I, Formula II, and Formula III. Methods of their use and preparation are also described.
We found 15 documents that match your Search
Patents: 13
Clinical Trials: 2

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in